Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 427 of the 428 references it cites were found in a registry or an index; 82 of the 464 sources its claims cite were checked for support.

TGFβ biology in cancer progression and immunotherapy

Open access
Derynck, Rik, Turley, Shannon J., Akhurst, Rosemary J.·2021·Nature Reviews Clinical Oncology

Abstract

TGFβ signalling has key roles in cancer progression: most carcinoma cells have inactivated their epithelial antiproliferative response and benefit from increased TGFβ expression and autocrine TGFβ signalling through effects on gene expression, release of immunosuppressive cytokines and epithelial plasticity. As a result, TGFβ enables cancer cell invasion and dissemination, stem cell properties and therapeutic resistance. TGFβ released by cancer cells, stromal fibroblasts and other cells in the tumour microenvironment further promotes cancer progression by shaping the architecture of the tumour and by suppressing the antitumour activities of immune cells, thus generating an immunosuppressive environment that prevents or attenuates the efficacy of anticancer immunotherapies. The repression of TGFβ signalling is therefore considered a prerequisite and major avenue to enhance the efficacy of current and forthcoming immunotherapies, including in tumours comprising cancer cells that are not TGFβ responsive. Herein, we introduce the mechanisms underlying TGFβ signalling in tumours and their microenvironment and discuss approaches to inhibit these signalling mechanisms as well as the use of these approaches in cancer immunotherapies and their potential adverse effects.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41571-020-0403-1

Cites

427 of 427 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

35 Valid · 6 Not valid · 182 Not checked · 57 Own results and interpretations

165 more claims · 35 with their cited sources checked

Create a free account to see all 280 claims and to verify the 382 references still open.

See all claims — free account
  • It may state two separate claims as one. 104
  • Probably not a substantial claim. 9
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 428 references

Research works printed but not linked: 1

  1. Reed, N. I. et al. The αvβ1 integrin plays a critical in vivo role in tissue fibrosis. Sci. Transl Med. 7, 288ra279 (2015).

Cited by

See all 967

Metadata

Authors
Derynck, R., Turley, S. J., & Akhurst, R. J.
Affiliations
  • University of California, San Francisco (US)
  • Genentech (US)
Corresponding author
  • Derynck, Rik
  • Turley, Shannon J.
  • Akhurst, Rosemary J.
Venue
Nature Reviews Clinical Oncology
Published
2020-07-24
Volume
18
Issue
1
Pages
9-34
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W3044737312
Cited by
944
References
428
Citations by year
2026: 147 · 2025: 191 · 2024: 195 · 2023: 167 · 2022: 151 · 2021: 81 · 2020: 9
FWCI
10.05
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
National Cancer Institute (R01CA210561)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
TGF-beta signaling, tumor progression, tumor microenvironment, cancer immunotherapy, immunosuppression, epithelial plasticity, cancer stemness, treatment resistance, tumor invasion, stromal fibroblasts, TGF-beta inhibition
MeSH terms
Animals, Humans, Immunotherapy, Neoplasms, Signal Transduction, Transforming Growth Factor beta, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TGFβ biology in cancer progression and immunotherapy. https://app.cochat.ai/papers/10.1038/s41571-020-0403-1
The paper
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021). TGFβ biology in cancer progression and immunotherapy. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-020-0403-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.